ALTLawsuits•prnewswire•
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
Sentiment:Negative (-70)
Summary
(NASDAQ:ALT) NEW YORK, Sept. 1, 2025 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. (NASDAQ: ALT) between August 10, 2023 and June 25, 2025, both dates inclusive (the "Class Period"), of the important October 6, 2025 lead...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 1, 2025 by prnewswire